- Statin attenuates cell proliferative ability via TAZ (WWTR1) in hepatocellular carcinoma
Takaaki Higashi et al, 2016, Med Oncol CrossRef - Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade
Jiaoyuan Jia et al, 2017, PLoS ONE CrossRef - Overexpression of Yes-associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta-analysis.
Chengjie Lin et al, 2017, Liver Int CrossRef - Early growth response 3 inhibits growth of hepatocellular carcinoma cells via upregulation of Fas ligand
Shujuan Zhang et al, 2017 CrossRef - Decitabine augments cytotoxicity of cisplatin and doxorubicin to bladder cancer cells by activating hippo pathway through RASSF1A
Madhuram Khandelwal et al, 2018, Mol Cell Biochem CrossRef - The Role of Autophagy in Hepatocellular Carcinoma
Yoo Lee et al, 2015, IJMS CrossRef - null
Yulei Zhao et al, 2019 CrossRef - Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells
Ting Lu et al, 2018, Biomedicine & Pharmacotherapy CrossRef - miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
Minjiang Chen et al, 2018, EBioMedicine CrossRef - Yes-associated protein promotes the abnormal proliferation of psoriatic keratinocytes via an amphiregulin dependent pathway
Jinjing Jia et al, 2018, Sci Rep CrossRef - Molecular evidence for better efficacy of hypocrellin A and oleanolic acid combination in suppression of HCC growth
Lin Wang et al, 2018, European Journal of Pharmacology CrossRef - Yes-Associated Protein Contributes to the Development of Human Cutaneous Squamous Cell Carcinoma via Activation of RAS
Jinjing Jia et al, 2016, Journal of Investigative Dermatology CrossRef - Cluster of Differentiation 166 (CD166) Regulated by Phosphatidylinositide 3-Kinase (PI3K)/AKT Signaling to Exert Its Anti-apoptotic Role via Yes-associated Protein (YAP) in Liver Cancer
Lifang Ma et al, 2014, J. Biol. Chem. CrossRef - The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells
Chang-En Yang et al, 2019, Chemico-Biological Interactions CrossRef - High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
Hyuk Moon et al, 2019, IJMS CrossRef - DYSREGULATION OF THE HIPPO PATHWAY SIGNALING IN AGING AND CANCER
Yiu To Yeung et al, 2019, Pharmacological Research CrossRef - YAP/TAZ Signaling and Resistance to Cancer Therapy
Chan D.K. Nguyen et al, 2019, Trends in Cancer CrossRef - miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells
T Higashi et al, 2015, Br J Cancer CrossRef - The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.
Randy Johnson et al, 2014, Nat Rev Drug Discov CrossRef - Hippo Pathway in Cancer: Aberrant Regulation and Therapeutic Opportunities
Philamer C. Calses et al, 2019, Trends in Cancer CrossRef - Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC)
Ping-Chih Hsu et al, 2019, IJMS CrossRef - Activation of β-Catenin and Yap1 in Human Hepatoblastoma and Induction of Hepatocarcinogenesis in Mice
Junyan Tao et al, 2014, Gastroenterology CrossRef - YAP1 is a potential biomarker for cetuximab resistance in head and neck cancer
Fredrik Jerhammar et al, 2014, Oral Oncology CrossRef - The Hippo pathway in chemotherapeutic drug resistance
Yulei Zhao et al, 2015, Int. J. Cancer CrossRef - Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy
Delin Kong et al, 2015, Journal of Drug Targeting CrossRef - Tumour promotion versus tumour suppression in chronic hepatic iron overload
Steven A. Bloomer et al, 2015, Cell Biochem Funct CrossRef - ARK5 promotes doxorubicin resistance in hepatocellular carcinoma via epithelial–mesenchymal transition
Tao Xu et al, 2016, Cancer Letters CrossRef - CRISPR Loss-of-Function Screen Identifies the Hippo Signaling Pathway as the Mediator of Regorafenib Efficacy in Hepatocellular Carcinoma
Shigeki Suemura et al, 2019, Cancers CrossRef - null
Cathie M. Pfleger, 2017 CrossRef - The Hippo pathway in hepatocellular carcinoma: Non-coding RNAs in action
Xuan Shi et al, 2017, Cancer Letters CrossRef - Artemisinin suppresses hepatocellular carcinoma cell growth, migration and invasion by targeting cellular bioenergetics and Hippo-YAP signaling
Yujie Li et al, 2019, Arch Toxicol CrossRef - RASSF1A–Hippo pathway link in patients with urothelial carcinoma of bladder: plausible therapeutic target
Madhuram Khandelwal et al, 2019, Mol Cell Biochem CrossRef - Involvement of Yes‐associated protein 1 (YAP1) in doxorubicin‐induced cytotoxicity in H9c2 cardiac cells
Akira Takaguri et al, 2019, Cell Biol Int CrossRef - NUAK2 localization in normal skin and its expression in a variety of skin tumors with YAP
Hind Al-Busani et al, 2020, Journal of Dermatological Science CrossRef - The YAP signaling pathway promotes the progression of lymphatic malformations through the activation of lymphatic endothelial cells
Wenqun Zhong et al, 2020, Pediatr Res CrossRef - Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP
Yu Tian et al, 2016, Oncotarget CrossRef - YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways
Daniel Andrade et al, 2017, Oncotarget CrossRef - YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo
Dan Sun et al, 2016, Oncotarget CrossRef - YAP and 14-3-3γ are involved in HS-OA-induced growth inhibition of hepatocellular carcinoma cells: A novel mechanism for hydrogen sulfide releasing oleanolic acid
Guanglin Xu et al, 2016, Oncotarget CrossRef - Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway
Meiyuan Chen et al, 2015, Oncotarget CrossRef - ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer
Qiongrong Chen et al, 2015, Oncotarget CrossRef - YAP is a critical oncogene in human cholangiocarcinoma
Tiemin Pei et al, 2015, Oncotarget CrossRef - Doxorubicin induces apoptosis by targeting Madcam1 and AKT and inhibiting protein translation initiation in hepatocellular carcinoma cells
Jiayi Wang et al, 2015, Oncotarget CrossRef - The Crosstalk between Src and Hippo/YAP Signaling Pathways in Non-Small Cell Lung Cancer (NSCLC).
Ping-Chih Hsu et al, 2020, Cancers (Basel) CrossRef - miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway.
Manman Xu et al, 0 CrossRef - Chemoresistance‑related long non‑coding RNA expression profiles in human breast cancer cells
Lei Huang et al, 2018, Mol Med Report CrossRef - Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells.
Xiaoguang Wang et al, 2018, Oncol Lett CrossRef - Role of YAP in lung cancer resistance to cisplatin
Juan Song et al, 2018, Oncol Lett CrossRef - A Novel YAP1 Inhibitor Targets CSC-Enriched Radiation-Resistant Cells and Exerts Strong Antitumor Activity in Esophageal Adenocarcinoma
Shumei Song et al, 2018, Mol Cancer Ther CrossRef - The Hippo Signaling Pathway in Drug Resistance in Cancer
Renya Zeng et al, 2021, Cancers CrossRef - MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer
Na-Hyun Lee et al, 2021, Biomedicines CrossRef - miR‑375/Yes‑associated protein axis regulates IL‑6 and TGF‑β expression, which is involved in the cisplatin‑induced resistance of liver cancer cells
Kanru Yu et al, 2021, Oncol Rep CrossRef - A Yes-Associated Protein (YAP) and Insulin-Like Growth Factor 1 Receptor (IGF-1R) Signaling Loop Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma
Mai-Huong T. Ngo et al, 2021, Cancers CrossRef - An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
Hina Qayoom et al, 2021, Future Oncology CrossRef - Up-regulation of the Hippo pathway effector TAZ renders lung adenocarcinoma cells harboring EGFR-T790M mutation resistant to gefitinib.
Wei Xu et al, 2015, Cell Biosci CrossRef - The dual role of microRNA-9 in gastrointestinal cancers: oncomiR or tumor suppressor?
Afsane Bahrami et al, 2022, Biomedicine & Pharmacotherapy CrossRef - Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment
Simran Kaur et al, 2021, BCTT CrossRef - Transcriptional co‐activators YAP1–TAZ of Hippo signalling in doxorubicin‐induced cardiomyopathy
Tünde Berecz et al, 2021, ESC Heart Failure CrossRef - null
Ankit Banik et al, 2022 CrossRef - N6-Methyladenosine Reader YTHDF2 Enhances Non-Small-Cell Lung Cancer Cell Proliferation and Metastasis through Mediating circ_SFMBT2 Degradation
Jing Xu et al, 2022, Contrast Media & Molecular Imaging CrossRef - Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases
Ruojun Li et al, 2023, IJMS CrossRef - Dysregulated YAP1/Hippo Pathway Contributes to Doxorubicin (ADM)
Resistance in Acute Myeloid Leukemia (AML)
Yan Song et al, 2023, CPB CrossRef - YAP1 Recognizes Inflammatory and Mechanical Cues to Exacerbate Benign Prostatic Hyperplasia via Promoting Cell Survival and Fibrosis
Dongxu Lin et al, 2023, Advanced Science CrossRef - Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
Xiaoting Luo et al, 2024, MedComm CrossRef - Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers
Hongge Liang et al, 2024, Cancer Gene Ther CrossRef - Genetic dependencies associated with transcription factor activities in human cancer cell lines
Venu Thatikonda et al, 2024, Cell Reports CrossRef